Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.
Agilent Technologies Inc. (NYSE: A) is a global company in analytical and clinical laboratory technologies, and its news flow reflects activity across life sciences, diagnostics, and applied markets. Company announcements highlight how Agilent’s instruments, software, services, and expertise are used to help customers bring great science to life, as well as how it manages its financial performance and corporate governance.
On this page, readers can follow Agilent news related to earnings results, product introductions, regulatory-focused solutions, capital allocation, and investor events. Recent releases include quarterly and full-year financial results, with details on revenue, net income, and segment performance for the Life Sciences and Diagnostics Markets Group, the Agilent CrossLab Group, and the Applied Markets Group. These updates often include management commentary on business conditions and outlook.
Agilent’s news also covers product and technology developments. For example, the company has announced 21 CFR Part 11 compliance software for the xCELLigence RTCA eSight system, designed to support use in GMP-regulated manufacturing and quality control environments by adding secure user authentication, electronic signatures, and audit trails. Another announcement introduced Agilent Altura Ultra Inert HPLC Columns, described as high performance liquid chromatography columns suited for biotherapeutics applications such as peptide GLP-1 and oligonucleotide therapeutic development and quality control.
Investors and analysts can also find updates on capital markets activities, such as cash dividend declarations on Agilent’s common stock, and notices of participation in healthcare and investor conferences. Governance-related news, including leadership transitions and executive appointments, is communicated through press releases and related SEC filings. Bookmarking this page allows users to review Agilent’s ongoing communications about its operations, technologies, financial performance, and corporate developments in one place.
TORM plc (A) has issued formal notice and full proposals for its Annual General Meeting to be held at noon London time on Wednesday, 15 April 2026. The notice details the business to be proposed at the AGM and provides investor contact names and phone numbers for queries.
TORM plc (Nasdaq: A) has adopted a long-term incentive program granting Restricted Share Units (RSUs) to employees and Executive Director Jacob Meldgaard. For 2025, 1,356,087 RSUs will be granted and 255,200 RSUs to Jacob Meldgaard, vesting over three years from 01 January 2027.
Each RSU may be exercised for one TORM A-share at an exercise price of DKK 167.14; theoretical market value of the allocation is USD 10.9m. P&L impact is forecast at USD 6.2m (2026), 3.3m (2027) and 1.4m (2028).
TORM (A) reported full-year 2025 results with TCE USD 910m, adjusted EBITDA USD 578m and net profit USD 286m. Return on invested capital fell to 11.5% from 24.3% in 2024. The Board approved a Q4 dividend of USD 0.70 per share payable 25 March 2026. For 2026 TORM expects TCE USD 850–1,250m and EBITDA USD 500–900m, with 23% of 2026 earning days covered as of 17 February 2026.
Fleet activity included nine second-hand acquisitions, purchase options exercised on 14 leaseback vessels, and a year-end fleet of 93 vessels.
Agilent (NYSE: A) reported Q1 FY2026 revenue of $1.80 billion, up 7.0% reported and 4.4% core year-over-year, with GAAP EPS of $1.07 and non-GAAP EPS of $1.36. The company raised FY26 revenue guidance to $7.3–$7.5 billion and increased non-GAAP EPS range to $5.90–$6.04.
Segments: LDG revenue $679M (16.0% margin), ACG $758M (31.6% margin), AMG $361M (25.8% margin). Q2 revenue guide is $1.79–$1.82 billion; Q2 non-GAAP EPS $1.39–$1.42. Management cited weather headwinds but reaffirmed core growth and margin expansion.
Agilent (NYSE: A) will participate in TD Cowen’s 46th Annual Health Care Conference with a fireside chat featuring CFO Adam Elinoff and Head of Investor Relations Tejas Savant on March 3, 2026, 11:10–11:40 a.m. EST in Boston.
A live audio webcast and replay will be available on Agilent’s Investor Relations website. Agilent reported $6.95 billion revenue for fiscal 2025 and employs approximately 18,000 people worldwide.
Agilent (NYSE: A) announced a quarterly cash dividend of 25.5 cents per share, payable April 22, 2026, to shareholders of record at the close of business March 31, 2026. The company said future dividend timing and amounts remain subject to board determination.
Financials: Agilent reported $6.95 billion revenue in fiscal 2025 and employs approximately 18,000 people worldwide.
Agilent (NYSE: A) awarded Boehringer Ingelheim the inaugural 2025 Instrument Trade‑In Impact Award for leading Agilent partners in sustainable trade‑in activity. In 2025 Boehringer Ingelheim diverted 6,600 kg of instrument waste from landfill via reuse, refurbishment, or proper recycling.
The award recognizes measurable progress toward a circular economy and supports Agilent’s programs to reduce laboratory waste and extend instrument lifecycles.
Agilent (NYSE: A) announced FDA approval of PD-L1 IHC 22C3 pharmDx, Code SK006 as the only FDA‑approved companion diagnostic to identify first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma (EOC) patients whose tumors express PD‑L1 and may be eligible for KEYTRUDA.
This marks the seventh FDA companion diagnostic indication for the test and enables PD‑L1 assessment at diagnosis to support first‑line treatment decisions; Agilent reported $6.95 billion revenue in fiscal 2025.
Agilent (NYSE: A) will showcase next‑generation automated workflow solutions at SLAS2026 in Boston, Feb 7–11, 2026. The company will demo integrated imaging, robotics partnerships, AI‑driven CrossLab Connect enhancements, a new Cytation imaging platform preview, ProteoAnalyzer Software Security Module, and updated Bravo liquid‑handling protocols.
The exhibits include multi‑vendor integrations with ABB Robotics, HighRes Biosolutions, Biosero, and Unite Labs, two exhibitor tutorials, a spotlight presentation, and participation in conference panels.
Agilent (NYSE: A) will report first-quarter fiscal 2026 results after market close on Feb. 25, 2026 and will host a listen-only conference call/webcast at 1:30 p.m. PST the same day.
A recording will be available on the company's investor relations site for 90 days. Agilent reported $6.95 billion revenue in fiscal 2025 and employs about 18,000 people worldwide.